Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/67N0 stock hub

FRA/67N0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/67N0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

606.2M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/67N0FRA/67N0

—

Loading chart…

In the news

Latest news · FRA/67N0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E12.5

P25 n/aP50 n/aP75 n/a

ROE12.8

P25 n/aP50 n/aP75 n/a

ROIC11.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/67N0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

CNY

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	1,545
Enterprise value	EUR 657.8M
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 606.2M
Price	EUR 0.29
Price currency	EUR
Rev Per Employee	196,048.71x
Sic	2836
Symbol	fra/67N0
Website	https://www.eddingpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.02%
EV Earnings	13.53x
EV/EBIT	8.57x
EV/EBITDA	6.22x
EV/FCF	13.34x
EV/Sales	2.19x
FCF yield	8.14%
P/B ratio	1.29x
P/E ratio	12.47x
P/S ratio	2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.56%
EBITDA Margin	34.27%
FCF margin	16.28%
Gross margin	68.15%
Gross Profit	EUR 206.4M
Gross Profit Growth	9.19%
Gross Profit Growth Q	17.98%
Net Income	EUR 48.6M
Net Income Growth	2.93%
Net Income Growth Q	145.7%
Pretax Margin	19.95%
Profit Margin	16.05%
Profit Per Employee	EUR 31,468
ROA	6.6
ROCE	14.48
ROE	12.75
ROIC	11.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	36.14%
Cagr3y	18.87%
Cagr5y	-29.35%
EPS Growth	1.04
FCF Growth	-54.47%
FCF Growth Q	-76.05%
OCF Growth	-50.67%
OCF Growth Q	-72.7%
Revenue Growth	-2.3x
Revenue Growth Q	15.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.41
Assets	EUR 804M
Cash	EUR 128.6M
Current Assets	EUR 274.4M
Current Liabilities	EUR 275.7M
Debt	EUR 181M
Debt EBITDA	EUR 1.7
Debt Equity	EUR 0.39
Debt FCF	EUR 3.67
Equity	EUR 468.9M
Interest Coverage	3.86
Liabilities	EUR 335.1M
Long Term Assets	EUR 529.6M
Long Term Liabilities	EUR 59.4M
Net Cash	EUR -52.4M
Net Cash By Market Cap	EUR -8.64
Net Debt EBITDA	EUR 0.5
Net Debt Equity	EUR 0.11
Net Debt FCF	EUR 1.06
Tangible Book Value	EUR 26.3M
Tangible Book Value Per Share	EUR 0.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1
Inventory Turnover	1.61
Net Working Capital	EUR 2.2M
Quick ratio	0.78
Working Capital	EUR -1.3M
Working Capital Turnover	EUR -0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	36.11%
200-day SMA	0.35
3Y total return	68%
50-day SMA	0.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-82.4%
All Time High	2.02
All Time High Change	-85.45%
All Time High Date	2021-07-01
All Time Low	0.08
All Time Low Change	247.93%
All Time Low Date	2024-01-12
ATR	0.01
Ch YTD	-12.5
High	0.29
High52	0.57
High52 Date	2025-09-03
High52ch	-48.42%
Low	0.29
Low52	0.21
Low52 Date	2025-05-12
Low52ch	42.72%
Ma50ch	-3.29%
Price vs 200-day SMA	-15.93%
RSI	39.66
RSI Monthly	49.31
RSI Weekly	46.99
Sharpe ratio	0.63x
Sortino ratio	1.22
Total Return	-1.86%
Tr YTD	-12.5
Tr1w	-4.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 77.4M
Operating Income Growth	27.35
Operating Income Growth Q	61.91
Operating margin	25.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	712,374,709%
Net Borrowing	-63,009,257.3
Shares Insiders	32.39%
Shares Institutions	8.21%
Shares Qo Q	472.73%
Shares Yo Y	1.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 43M
Average Volume	0x
Bv Per Share	0.23
CAPEX	EUR -5.7M
Ch1w	-4.55
Ch1y	36.11
Ch3y	68
Ch5y	-82.4
Ch6m	6.52
Change	-2%
Change From Open	0
Close	0.3
Days Gap	-2
Depreciation Amortization	27,025,983.3
Earnings Date	2026-03-27
EBIT	EUR 77.4M
EBITDA	EUR 103.8M
EPS	EUR 0.03
F Score	7
FCF	EUR 49.3M
FCF EV Yield	7.5x
Financing CF	-90,691,487
Fiscal Year End	December
Founded	2,001
Goodwill	49,777,494
Graham Number	0.34734
Graham Upside	18.14
Income Tax	EUR 11.8M
Investing CF	151,090,538
Is Primary Listing	0
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Ma150	0.33
Ma150ch	-9.62%
Ma20	0.33
Ma20ch	-10.64%
Net CF	114,856,270
Open	0.29
P FCF Ratio	12.29
P OCF Ratio	11.02
Ppne	42,218,802.1
Price Date	2026-05-08
Price EBITDA	EUR 5.84
Ptbv Ratio	23.07
Relative Volume	20x
Revenue	302,895,250x
SBC By Revenue	2.08x
Share Based Comp	6,313,349
Tax By Revenue	3.9x
Tax Rate	19.55%
Tr6m	6.52%
Volume	0
Z Score	1.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/67N0 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/67N0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/67N0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.2%

Share of float held by funds and institutions

Insider ownership

+32.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.9%

Negative means the company is buying back shares.

Technical

FRA/67N0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.7

Neutral momentum band

Price vs 200-day MA

-15.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/67N0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/67N0 stock rating?

fra/67N0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/67N0 analysis?

The full report lives at /stocks/fra/67N0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/67N0?

The latest report frames fra/67N0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/67N0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.